Bezwada Biomedical Research Profile
Key Indicators
- Authorised Capital ₹ 1.25 Cr
as on 07-07-2024
- Paid Up Capital ₹ 1.17 Cr
as on 07-07-2024
- Company Age 21 Year, 1 Month
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 1.51 Cr
as on 07-07-2024
- Satisfied Charges ₹ 1.09 Cr
as on 07-07-2024
- Revenue 24.27%
(FY 2023)
- Profit 8.27%
(FY 2023)
- Ebitda 1.27%
(FY 2023)
- Net Worth 49.96%
(FY 2023)
- Total Assets 20.06%
(FY 2023)
About Bezwada Biomedical Research
The Company is engaged in the Chemicals And Materials Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.25 Cr and a paid-up capital of Rs 1.17 Cr.
The company currently has active open charges totaling ₹1.51 Cr. The company has closed loans amounting to ₹1.09 Cr, as per Ministry of Corporate Affairs (MCA) records.
Ravipati Shrivani, Koteswaramma Bezwada, Rao Bezwada, and One other member serve as directors at the Company.
- CIN/LLPIN
U24239AP2003PTC042066
- Company No.
042066
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
14 Nov 2003
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Vijayawada
Industry
Company Details
- Location
Jammulapalem Village Tanguturu Mandal, Andhra Pradesh, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Bezwada Biomedical Research?
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Ravipati Shrivani  | Additional Director | 28-Feb-2013 | Current |
Koteswaramma Bezwada  | Additional Director | 06-Aug-2021 | Current |
| Rao Bezwada | Director | 14-Nov-2003 | Current |
| Venkata Bezawada | Director | 14-Nov-2003 | Current |
Financial Performance of Bezwada Biomedical Research.
Bezwada Biomedical Research Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 24.27% increase. The company also saw a slight improvement in profitability, with a 8.27% increase in profit. The company's net worth Soared by an impressive increase of 49.96%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Bezwada Biomedical Research?
In 2023, Bezwada Biomedical Research had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Canara Bank Creation Date: 02 Aug 2022 | ₹2.67 M | Open |
Syndicate Bank Creation Date: 06 Mar 2019 | ₹1.24 Cr | Open |
Indian Overseas Bank Creation Date: 03 Jun 2014 | ₹0.90 M | Satisfied |
How Many Employees Work at Bezwada Biomedical Research?
Unlock and access historical data on people associated with Bezwada Biomedical Research, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Bezwada Biomedical Research, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Bezwada Biomedical Research's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
